Trial: 202001135

ADVL1823 – Larotrectinib (LOXO-101, NSC# 788607, IND# 141824) for Previously Untreated TRK Fusion Pediatric Solid Tumors and TRK Fusion Relapsed Pediatric Acute Leukemias

Phase

II

Principal Investigator

Hayashi, Robert

Disease Site

Bones and Joints; Brain and Nervous System; Eye and Orbit; Kidney; Leukemia, other; Liver; Lymphoid Leukemia; Melanoma, Skin; Myeloid and Monocytic Leukemia; Other Digestive Organ; Other Endocrine System; Other Female Genital; Other Male Genital; Other Respiratory and Intrathoracic Organs; Other Skin; Other Urinary; Soft Tissue; Stomach; Thyroid

Learn more about this study at: clinicaltrials.gov